5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one

CAS: 183208-34-6

Ref. 3D-FB42029

Produktinformation

• Name: 5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
• Synonyme: 5-Bromo-7-Aza-Indolin-2(3h)-One, 2H-Pyrrolo[2,3-b]pyridin-2-one, 5-bromo-1,3-dihydro-, 5-bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one, 5-bromo-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-one

Beschreibung

5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one is a cancer drug that is a potent inhibitor of angiogenesis. This compound has been shown to inhibit tumor growth in vitro and in vivo. 5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one also shows antiangiogenic activity in mouse models of cancer. The antitumor effects of this drug are mediated by inhibition of the protein tyrosine kinases VEGF receptor 1 (VEGFR1) and VEGFR2. Sunitinib is an oral anticancer agent used for the treatment of metastatic renal cell carcinoma and other solid tumors. It has been found to be active against a variety of human cancers including melanomas, lung cancers, breast

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 213.03 g/mol
• Formel: C₇H₅BrN₂O
• Reinheit: Min. 95%
• InChl: InChI=1S/C7H5BrN2O/c8-5-1-4-2-6(11)10-7(4)9-3-5/h1,3H,2H2,(H,9,10,11)
• InChI Key: InChIKey=DHPKTHROZFIEJK-UHFFFAOYSA-N
• SMILES: O=C1Cc2cc(Br)cnc2N1